Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Germ Cell and Embryonal × Epirubicin × 30 days × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 1 Resectable HER2-positive Breast Cancer 1 Non-Muscle Invasive Bladder Neoplasms 1 Breast Neoplasms 1

Interventions

Etoposide 2 Cyclophosphamide 2 Cisplatin 2 Carboplatin 2 pralsetinib 1 pembrolizumab 1 fludarabine phosphate 1 fludarabine 1 etoposide phosphate 1 Standard of Care 1 Specimen Handling 1 Sirolimus 1 Respiratory Physiological Phenomena 1 Practice Guidelines as Topic 1 Platinum 1 Pemetrexed 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Gemcitabine 1 Celecoxib 1 Bleomycin 1 Biopsy 1 130-nm albumin-bound paclitaxel 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡